Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.13
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.44 (4.938%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.13
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BBVA Dividend option

11 Apr 2012 18:22

RNS Number : 1696B
Banco Bilbao Vizcaya Argentaria SA
11 April 2012
 

 

 

Banco Bilbao Vizcaya Argentaria, S.A.(BBVA), in compliance with the Securities Market legislation, hereby communicates the following:

 

 

 

RELEVANT EVENT

In connection with the relevant event of March 28, 2012 (Filing No. 160866), BBVA hereby submits, for purposes of articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005 of November 4, this supplementary document to the Information Document relating to the free-of-charge capital increase by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented.

 

Madrid, April 11, 2012

 

supplementary document to the Information Document

 

CAPITAL INCREASE CHARGED TO VOLUNTARY RESERVES

 

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

 

 

April 11, 2012

 

  

THIS DOCUMENT HAS BEEN PREPARED IN ACCORDANCE WITH ARTICLES 26.1.E) AND 41.1.D) OF ROYAL DECREE 1310/2005 OF NOVEMBER 4.

 

Disclaimer: The English version is a free translation of the original in Spanish for information purposes only. In the event of discrepancy, the Spanish original will prevail

1. INTRODUCTION

This document (the "Supplementary Document") has been issued to supplement the information provided in the information document relating to the capital increase charged to voluntary reserves approved by the ordinary general shareholders' meeting of Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Bank") held on March 16, 2012, under item 4.1 of the fourth point of its agenda (the "Capital Increase"), which was published by means of a relevant event on March 28, 2012, with filing number 160866 (the "Information Document"). Capitalized terms used but not defined herein have the meanings assigned to them in the Information Document.

This Supplementary Document sets forth below the information relating to the Capital Increase which was outstanding at the date of publication of the Information Document and, in particular, the number of shares to be issued (with the possibility of incomplete subscription being expressly provided for), the number of free allotment rights necessary to receive one new share ("NAR") and the price at which BBVA has undertaken to acquire free allotment rights from shareholders, in the terms set forth in the Information Document.

This Supplementary Document and the Information Document have been issued in accordance with articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005, of November 4, which provide that the preparation and publication of a prospectus related to the issuance and admission to listing of the shares issued as a consequence of the execution of the Capital Increase will not be necessary "provided that a document is made available containing information on the number and nature of the shares and the reasons for and details of the offer". This Supplementary Document together with the Information Document constitute such document. This Supplementary Document and the Information Document are available on the CNMV's website (www.cnmv.es) and the Bank's website (www.bbva.com).

2. SUPPLEMENTARY INFORMATION TO THE INFORMATION DOCUMENT

The Executive Committee of BBVA, in its meeting held on April 11, 2012, has agreed to implement the Capital Increase in accordance with the terms approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012. In accordance with the formulas approved by these bodies, the Executive Committee has approved the following parameters concerning the Capital Increase:

(i) The number of new shares to be issued as a consequence of the execution of the Capital Increase ("New Shares") will be 107,682,603 New Shares. Accordingly, the aggregate nominal value of the Capital Increase will be €52,764,475.47, which is the product of multiplying the number of New Shares 107,682,603 by the nominal value of €0.49 per New Share.

The number of New Shares to be issued is the result of applying the formulas provided for in the applicable resolution adopted by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012, considering that the number of old shares outstanding is 5,061,082,3781 ("NOS"), that the reference market value is €615,000,000 ("RMV") and that the reference price is €5.677 ("reference price" or "RP").2 On this basis:

(a) The number of rights to be assigned ("rights to be assigned" or "NAR") is 47, in accordance with the formula in the shareholders' and board's resolutions (rounded up to the nearest whole number):

NAR = RP x NOS / RMV

which, as applied, results in:

NAR = €5.677 x 5,061,082,378 / 615,000,000 = 47

(b) The number of New Shares to be issued is 107,682,603 New Shares, in accordance with the formula in the shareholders' and board's resolutions (rounded down to the nearest whole number):

New Shares = NOS / NAR

which, as applied, results in:

New Shares = 5,061,082,378 / 47 = 107,682,603

Notwithstanding this, the number of New Shares actually issued and, as a result, the nominal value of the Capital Increase may be less than the foregoing depending on the number of rights acquired by the Bank pursuant to its undertaking to acquire the free allotment rights for a fixed price. BBVA will waive the free allotment rights acquired pursuant to such undertaking. As a result, only those shares corresponding to the free allotment rights which have not been acquired by BBVA pursuant to its undertaking will be issued.

The New Shares will be issued at their nominal value of forty-nine euro cents (€0.49) per New Share, without issuance premium.

1 This amount reflects the voluntary conversion into shares, at the option of the holders, of BBVA’s mandatory convertible subordinated bonds issued in December 2011, after which the number of old shares outstanding is 5,061,082,378.
2 The Reference Price corresponds to the arithmetic mean of the weighted average prices of BBVA’s shares on the Spanish Stock Exchanges (Mercado Continuo) over the five trading sessions immediately prior to April 11, 2012, the date that BBVA’s Executive Committee resolved to effect the Capital Increase, rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro. 

(ii) The number of rights necessary to receive one New Share is 47.

BBVA shareholders who appear as such in the book-entry registries of Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A. ("Iberclear") at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for April 13, 2012) will receive a free allotment right for each BBVA share held. Consequently, such shareholders will have a right to receive one New Share for each 47 shares held by them on such date.

To ensure that all free allotment rights are effectively exercisable and that the number of New Shares to be issued is a whole number, BBVA has renounced 37 rights corresponding to 37 shares held as treasury shares.

(iii) The fixed purchase price of each freely allotted right assumed by BBVA is €0.118 per right, in accordance with the formula approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012 (rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro):

Purchase price = RP / (NAR +1)

which, as applied, results in:

Purchase price = 5.677 / (47 + 1) = €0.118

Accordingly, shareholders who wish to receive a dividend in cash can sell their rights to BBVA at a gross fixed price of €0.118 per right.

As indicated in the Information Document, this option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allotment rights are allocated and only in connection with the free allotment rights which are originally allocated to them at such time; accordingly, this option will not be available in respect of any free allotment right acquired through a market purchase.

BBVA's undertaking to acquire rights at this fixed price will be in effect from the first trading day of the rights, which is expected to take place on April 16, 2012 through April 25, 2012, both inclusive.3

3 The options, terms and procedures indicated in this information document may not be the same in respect of BBVA shares listed outside Spain, including in the form of BBVA ADSs.

* * *

Banco Bilbao Vizcaya Argentaria, S.A.

P.p.

Erik Schotkamp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIBMRTMBBBBTT
Date   Source Headline
3rd Feb 20227:12 amRNSSecond Tranche of the Share Buyback Program
3rd Feb 20227:10 amRNSShareholders' Remuneration
3rd Feb 20227:10 amRNSSREP Requirements
3rd Feb 20227:05 amRNS4Q21 Results Presentation
3rd Feb 20227:03 amRNS4Q21 Results Press Release
3rd Feb 20227:00 amRNS4Q21 Results Report
1st Feb 202210:21 amRNS220201_BBVA_SBB Follow up Reporting
25th Jan 202210:22 amRNS4Q21 Results Presentation Announcement
21st Jan 202211:58 amRNS220121_BBVA_SBB Follow up Reporting
14th Jan 202210:14 amRNS220114_BBVA_SBB Follow up Reporting
10th Jan 202211:21 amRNS220110_BBVA_SBB Follow up Reporting
6th Jan 202212:37 pmRNSPre-Stab Notice BBVA EUR 1bn due 14th Jan 2022
4th Jan 20227:00 amRNS220103_BBVA_Share Buyback Follow up Reporting
29th Dec 20219:34 amRNSBBVA_ Shares Buyback_Follow up Reporting
29th Dec 20217:00 amRNSBBVA Amendment to the Final Terms
29th Dec 20217:00 amRNSBBVA GBP Final Terms
17th Dec 202110:48 amRNS2021.12.17 Share Buyback Follow up Reporting
17th Dec 20217:00 amRNSS&P's Upgrades BBVA's ratings
10th Dec 202110:18 amRNSBBVA_ Shares Buyback_Follow up Reporting
1st Dec 202110:19 amRNSBBVA_ Shares Buyback_Follow up Reporting
26th Nov 202111:24 amRNSShares Buyback Follow up Reporting
19th Nov 20214:51 pmRNSBuyback Execution
18th Nov 202112:35 pmRNSBBVA_Investor_Day_Presentations
18th Nov 202112:28 pmRNSNew shareholder's distribution policy
18th Nov 20217:00 amRNSBBVA disclosure CMB application
16th Nov 20212:15 pmRNSInvestor Day Announcement
15th Nov 20217:20 amRNSAnalysts Call _ BBVA's Voluntary Takeover Bid
15th Nov 20217:03 amRNSVoluntary Takeover Bid for Türkiye Garanti Bankasi
29th Oct 20217:00 amRNS3Q21 Results Press Release
29th Oct 20217:00 amRNS3Q21 Results Presentation
29th Oct 20217:00 amRNSAuthorization Share Buyback
29th Oct 20217:00 amRNS3Q21 Results Report
19th Oct 202110:12 amRNS3Q21 Results Presentation Announcement
30th Sep 20217:47 amRNSDividend October 2021
30th Jul 20215:48 pmRNS2020 EU-wide Stress Test
30th Jul 20217:00 amRNS2Q21 Results Presentation
30th Jul 20217:00 amRNS2Q21 Results Press Release
30th Jul 20217:00 amRNS2Q21 Results Report
29th Jul 20216:18 pmRNSChanges in the Organizational Structure
21st Jul 202111:23 amRNS2Q21 Results Presentation Announcement
13th Jul 20215:21 pmRNSMoody's upgrades BBVA's Subordinated debt
1st Jul 20218:28 amRNSHR Selection of statutory auditor BBVA
9th Jun 20217:00 amRNSHR Agreement on the collective layoff
1st Jun 20212:47 pmRNSClosing BBVA USA sale
1st Jun 20217:00 amRNS2021 MREL Requirement
30th Apr 20217:18 amRNS1Q21 Results Presentation
30th Apr 20217:16 amRNS1Q21 Results Press Release
30th Apr 20217:14 amRNS1Q21 Results Report
23rd Apr 202110:29 amRNS1Q21 Results Presentation Announcement
20th Apr 20213:36 pmRNSPost-Stabilisation Notice - BBVA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.